Literature DB >> 31852200

Ameliorative effect of sesamin in cisplatin-induced nephrotoxicity in rats by suppressing inflammation, oxidative/nitrosative stress, and cellular damage.

B H Ali1, S Al Salam, Y Al Suleimani, M Al Za'abi, M Ashique, P Manoj, M Sudhadevi, M Al Tobi, A Nemmar.   

Abstract

Nephrotoxicity of cisplatin (CP) involves renal oxidative stress and inflammation, and sesamin (a major liganin in many plants) has strong antioxidant and antiinflammatory actions. Therefore, we investigated here the possible mitigative action of sesamin on CP nephrotoxicity in rats. Sesamin was given orally (5 mg/kg/day, 10 days), and on the 7th day, some of the treated rats were injected intraperitoneally with either saline or CP (5 mg/kg). On the 11th day, rats were sacrificed, and blood and urine samples and kidneys were collected for biochemical estimation of several traditional and novel indices of renal damage in plasma and urine, several oxidative and nitrosative indices in kidneys, and assessment of histopathological renal damage. CP significantly and adversely altered all the physiological, biochemical and histopathological indices of renal function measured. Kidneys of CP-treated rats had a moderate degree of necrosis. This was markedly lessened when CP was given simultaneously with sesamin. Sesamin treatment did not significantly alter the renal CP concentration. The results suggested that sesamin had ameliorated CP nephrotoxicity in rats by reversing the CP-induced oxidative stress and inflammation. Pending further pharmacological and toxicological studies sesamin may be considered a potentially useful nephroprotective agent.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31852200      PMCID: PMC8565953          DOI: 10.33549/physiolres.934142

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  46 in total

Review 1.  Clinically Relevant Biomarkers in Acute Heart Failure: An Update.

Authors:  Agnibh Mukherji; Uzair Ansari; Martin Borggrefe; Ibrahim Akin; Michael Behnes
Journal:  Curr Pharm Biotechnol       Date:  2017       Impact factor: 2.837

2.  Protective effect of lactoferrin on Cisplatin-induced nephrotoxicity in rats.

Authors:  Yumi Kimoto; Masaaki Nishinohara; Akihiko Sugiyama; Akihiro Haruna; Takashi Takeuchi
Journal:  J Vet Med Sci       Date:  2012-10-10       Impact factor: 1.267

Review 3.  Cisplatin-induced gastrointestinal toxicity: An update on possible mechanisms and on available gastroprotective strategies.

Authors:  Faaiza Shahid; Zeba Farooqui; Farah Khan
Journal:  Eur J Pharmacol       Date:  2018-03-09       Impact factor: 4.432

4.  Absorption, distribution, metabolism, and excretion of [14 C]sesamin in rats.

Authors:  Namino Tomimori; Tomohiro Rogi; Hiroshi Shibata
Journal:  Mol Nutr Food Res       Date:  2017-02-06       Impact factor: 5.914

5.  Sesamin prevents apoptosis and inflammation after experimental myocardial infarction by JNK and NF-κB pathways.

Authors:  Di Fan; Zheng Yang; Yuan Yuan; Qing-Qing Wu; Man Xu; Ya-Ge Jin; Qi-Zhu Tang
Journal:  Food Funct       Date:  2017-07-20       Impact factor: 5.396

Review 6.  Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

Authors:  N Pabla; Z Dong
Journal:  Kidney Int       Date:  2008-02-13       Impact factor: 10.612

7.  Effect of diesel exhaust particles on renal vascular responses in rats with chronic kidney disease.

Authors:  Y M Al Suleimani; A S Al Mahruqi; M Al Za'abi; A Shalaby; M Ashique; A Nemmar; B H Ali
Journal:  Environ Toxicol       Date:  2016-03-18       Impact factor: 4.119

8.  Long-Term Renal Outcomes after Cisplatin Treatment.

Authors:  Sheron Latcha; Edgar A Jaimes; Sujata Patil; Ilya G Glezerman; Swati Mehta; Carlos D Flombaum
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-12       Impact factor: 8.237

9.  Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas.

Authors:  Jantien Hoek; Karen M Bloemendal; Lilly-Ann A van der Velden; Judi N A van Diessen; Erik van Werkhoven; Willem M C Klop; Margot E T Tesselaar
Journal:  Cancers (Basel)       Date:  2016-02-16       Impact factor: 6.639

10.  Ameliorative Effect of Daidzein on Cisplatin-Induced Nephrotoxicity in Mice via Modulation of Inflammation, Oxidative Stress, and Cell Death.

Authors:  Hongzhou Meng; Guanghou Fu; Jie Shen; Kezhen Shen; Zhijie Xu; Yiming Wang; Baiye Jin; Hao Pan
Journal:  Oxid Med Cell Longev       Date:  2017-08-02       Impact factor: 6.543

View more
  5 in total

Review 1.  Lignans as Pharmacological Agents in Disorders Related to Oxidative Stress and Inflammation: Chemical Synthesis Approaches and Biological Activities.

Authors:  Dmitry I Osmakov; Aleksandr P Kalinovskii; Olga A Belozerova; Yaroslav A Andreev; Sergey A Kozlov
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

2.  The Nephroprotective Effects of α-Bisabolol in Cisplatin-Induced Acute Kidney Injury in Mice.

Authors:  Nur Elena Zaaba; Sumaya Beegam; Ozaz Elzaki; Javed Yasin; Bilal Mohamed Nemmar; Badreldin H Ali; Ernest Adeghate; Abderrahim Nemmar
Journal:  Biomedicines       Date:  2022-04-03

3.  The salutary action of melatonin and betaine, given singly or concomitantly, on cisplatin-induced nephrotoxicity in mice.

Authors:  Mohammed Al Za'abi; Haytham Ali; Mohammed Al Sabahi; Badreldin H Ali
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-18       Impact factor: 3.000

Review 4.  Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD+-Dependent Enzymes and Plant-Derived Natural Products.

Authors:  Amany Iskander; Liang-Jun Yan
Journal:  Biomolecules       Date:  2022-08-05

5.  The Protective Effects of Sesamin against Cyclophosphamide-Induced Nephrotoxicity through Modulation of Oxidative Stress, Inflammatory-Cytokines and Apoptosis in Rats.

Authors:  Saeed Alshahrani; Hani M Ali Thubab; Abdulrahman M Ali Zaeri; Tarique Anwer; Rayan A Ahmed; Abdulmajeed M Jali; Marwa Qadri; Yousra Nomier; Sivakumar S Moni; Mohammad F Alam
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.